Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696109 · ClinicalTrials.gov registry record · NA
Cornerstone Program for Transition-Age Youth Study Protocol for a Randomized Controlled Trial
A NA study of Depression and Bipolar Disorder, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT02696109: Completed NA study of Depression and Bipolar Disorder, sponsored by New York University.
NCT02696109 is a NA study of Depression and Bipolar Disorder that has completed, run by New York University. The registered enrollment target is 59 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02696109, a NA study of Depression and Bipolar Disorder, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is exploring a theoretically guided intervention, Cornerstone, which provides system 'boundary-spanning' services, including therapeutic services and mentorship, to transition-age youth with mental disorders. Cornerstone is designed to improve mental health service engagement and outcomes. The study uses a mixed methods approach to refine Cornerstone, and a hybrid design examining feasibility, acceptability, and preliminary impact with a randomized trial, alongside implementation.
Primary Outcome
Standardized scale developed and tested by Fishbein and colleagues
Conditions Studied
Interventions
- BEHAVIORAL Treatment As Usual
- BEHAVIORAL Cornerstone
Study Locations (1)
New York
- New York University Silver School of Social Work - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-11 |
| Phase | NA |
What the finished NCT02696109 record still lists
NCT02696109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual is the first listed.
NCT02696109 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02696109 about?
NCT02696109 is a clinical study titled "Cornerstone Program for Transition-Age Youth Study Protocol for a Randomized Controlled Trial". The purpose of this study is exploring a theoretically guided intervention, Cornerstone, which provides system 'boundary-spanning' services, including therapeutic services and mentorship, to transition-age youth with mental disorders. Cornerstone is designed to improve mental health service engageme...
What is the current status of trial NCT02696109?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2016-02. Estimated completion is 2018-11.
What conditions does trial NCT02696109 study?
This clinical trial studies the following conditions: Depression, Bipolar Disorder, Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT02696109?
The interventions under investigation include: Treatment As Usual (BEHAVIORAL), Cornerstone (BEHAVIORAL).
Who is sponsoring clinical trial NCT02696109?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02696109 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02696109's enrollment target sits among peer trials
59 447th of 679 higher than 232 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia